[37] showed that the STAT3 inhibitor napabucasin decreased the ALDH1-positive CSC population of non-small cell lung carcinoma cells whilst decreasing the mRNA expression of critical stemness genes. The gene discussed is ALDH1A1; the disease is non-small cell lung carcinoma.